99m technetium
Showing 1 - 25 of >10,000
Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)
Enrolling by invitation
- Prostate Cancer
- Whole body study and SPECT with [99mTc]Tc-BQ0413
-
Tomsk, Russian FederationTomskNRMC
Oct 26, 2023
Prostate Cancer, Breast Cancer Trial in Tomsk (Intravenous injection of [99mTc]Tc-DB8)
Recruiting
- Prostate Cancer
- Breast Cancer
- Intravenous injection of [99mTc]Tc-DB8
-
Tomsk, Russian FederationTomskNRMC
Jul 4, 2023
Ovarian Epithelial Cancer Trial (99mTC nanocolloid albumin injection, ICG injection)
Not yet recruiting
- Ovarian Epithelial Cancer
- 99mTC nanocolloid albumin injection
- ICG injection
- (no location specified)
Jul 6, 2023
Amyloidosis, Transthyretin Amyloid Cardiomyopathy Trial in Portland (99m-technetium pyrophosphate scintigraphy)
Recruiting
- Amyloidosis
- Transthyretin Amyloid Cardiomyopathy
- 99m-technetium pyrophosphate scintigraphy
-
Portland, OregonOregon Health & Science University
Feb 17, 2022
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Recruiting
- Hepatocellular Carcinoma
- Technetium-99m macroaggregated albumin (Tc-99m MAA)
-
Chicago, IllinoisNorthwestern University
Jan 17, 2023
Breast Tumor Trial in Rochester (procedure, other, radiation)
Recruiting
- Breast Neoplasm
- Biopsy of Breast
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 22, 2023
Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)
Recruiting
- Carcinoma
- +2 more
- 99mTc-Macro Albumin Aggregate
-
Spokane, WashingtonInland Imaging
May 4, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023
Prostate Cancer, Breast Cancer Female Trial in Tomsk (whole body study and SPECT with 99mTc-RM26)
Enrolling by invitation
- Prostate Cancer
- Breast Cancer Female
- whole body study and SPECT with 99mTc-RM26
-
Tomsk, Russian FederationTomskNRMC
Jul 4, 2022
Oropharynx Cancer Trial in Toronto (SPECT-CT)
Recruiting
- Oropharynx Cancer
- SPECT-CT
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Sep 14, 2021
Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)
Enrolling by invitation
- Breast Cancer Female
-
Tomsk, Russian FederationOlga
Jun 19, 2023
Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)
Active, not recruiting
- Metastatic Liver Carcinoma
- +3 more
- Angiography
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsense™ VS3 - Stereoscopic High Definition Visualisation System
Completed
- Malignant Melanoma
- Merkel Cell Carcinoma
- Visionsense™ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
-
Bern, Kanton Bern, SwitzerlandInselspital, University Hospital Bern, University of Bern
Dec 7, 2022
99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast
Enrolling by invitation
- Breast Cancer Female
- 99mTc-DARPinG3 SPECT/CT
-
Tomsk, Russian FederationRussia Tomsk NRMC
Jan 23, 2023
Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell
Active, not recruiting
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- +2 more
- Computed Tomography
- +7 more
-
Seattle, Washington
- +1 more
Jul 18, 2022
Breast Cancer Trial in Madison (SLN mapping using technetium-99m +/- isosulfan blue dye, SLN mapping with ICG fluorescence using
Recruiting
- Breast Cancer
- SLN mapping using technetium-99m +/- isosulfan blue dye
- SLN mapping with ICG fluorescence using the Asimov Platform
-
Madison, WisconsinUniversity of Wisconsin
May 15, 2023
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single
Recruiting
- Hepatocellular Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Seattle, Washington
- +1 more
Feb 24, 2022
Primary Ciliary Dyskinesia Trial in Chapel Hill (Albuterol, Technetium99m - Sulfur Colloid (Tc99m-SC))
Recruiting
- Primary Ciliary Dyskinesia
- Albuterol
- Technetium99m - Sulfur Colloid (Tc99m-SC)
-
Chapel Hill, North CarolinaUniversity of North Carolina Chapel Hill
Aug 10, 2022
Early Screening and Diagnosis of CKD
Recruiting
- Kidney; Disease (Functional)
- Chronic Kidney Disease
- 99mTc-DTPA
-
Nanjing, Jiangsu, ChinaNanjing First Hospital, Nanjing Medical University
Apr 5, 2022
Eyelid Sebaceous Gland Carcinoma Trial in Houston (Lymph Node Mapping, Sentinel Lymph Node Biopsy, Technetium Tc-99m Sulfur
Recruiting
- Eyelid Sebaceous Gland Carcinoma
- Lymph Node Mapping
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2021
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,
Active, not recruiting
- Estrogen Receptor Negative
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Houston, Texas
- +5 more
Feb 11, 2022